Bio/Pharma News

Aug 29, 2017
By Pharmaceutical Technology Editors
AstraZeneca and Takeda will partner to develop and commercialize MEDI1341, an alpha-synuclein antibody currently in development as a potential treatment for Parkinson’s disease (PD).
Aug 29, 2017
By Pharmaceutical Technology Editors
Gilead will gain a robust pipeline of cell therapy products, with one lead candidate, a CAR T therapy, anticipated to gain FDA approval in the fourth quarter.
Aug 28, 2017
By Pharmaceutical Technology Editors
The acquisition of Protein Sciences, a vaccines biotechnology company, strengthens Sanofi’s influenza vaccines portfolio.
Aug 28, 2017
By Pharmaceutical Technology Editors
Genentech gets priority review for its application seeking a new indication for its anti-cancer drug, Gazyva (obinutuzumab), in treating follicular lymphoma.
Aug 25, 2017
By Pharmaceutical Technology Editors
The generic pharmaceuticals firm has sold its Baddi, India formulations manufacturing facility following a recent fire at its joint-venture plant in Algeria.
Aug 24, 2017
By Pharmaceutical Technology Editors
Xellia Pharmaceuticals completed the expansion of its laboratory services building at its Budapest manufacturing site.
Aug 24, 2017
By Pharmaceutical Technology Editors
FDA grants priority review for emicizumab, an investigational bispecific monoclonal antibody, for treating hemophilia A with factor VIII inhibitors.
Aug 21, 2017
By Pharmaceutical Technology Editors
Shire announced that CFO Jeff Poulton will be leaving the company at the end of the year. Additionally, Joanne Cordeiro has been appointed as CHRO.
Aug 21, 2017
By Pharmaceutical Technology Editors
The first program of this collaboration will focus on the development of a candidate for severe acute pancreatitis.
Aug 18, 2017
By Pharmaceutical Technology Editors
The withdrawal has been attributed to issues at the biotech company’s manufacturing facility.
native1_300x100
lorem ipsum